167 related articles for article (PubMed ID: 33426002)
1. Variations in Energy Metabolism Precede Alterations in Cardiac Structure and Function in Hypertrophic Preconditioning.
Wu J; Lu J; Huang J; You J; Ding Z; Ma L; Dai F; Xu R; Li X; Yin P; Zhao G; Wang S; Yuan J; Yang X; Ge J; Zou Y
Front Cardiovasc Med; 2020; 7():602100. PubMed ID: 33426002
[TBL] [Abstract][Full Text] [Related]
2. Caspase-1 Abrogates the Salutary Effects of Hypertrophic Preconditioning in Pressure Overload Hearts via IL-1β and IL-18.
Dai F; Li X; Li X; Ding Z; Xu R; Yin P; Wang S; Ge J; Wu J; Zou Y
Front Mol Biosci; 2021; 8():641585. PubMed ID: 33842546
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound biomicroscopy validation of a murine model of cardiac hypertrophic preconditioning: comparison with a hemodynamic assessment.
Huang J; Wu J; Wang S; You J; Ye Y; Ding Z; Yang F; Wang X; Guo J; Ma L; Yuan J; Shen Y; Yang X; Sun A; Jiang H; Bu L; Backx PH; Ge J; Zou Y
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H138-H148. PubMed ID: 28455286
[TBL] [Abstract][Full Text] [Related]
4. An Optimized Model of Hypertrophic Preconditioning Confers Cardioprotection in the Mouse.
Cai X; Tian Y; Wu Y; Bonner MY; Zhuo X; Yuan Z
J Surg Res; 2021 Aug; 264():544-552. PubMed ID: 33864962
[TBL] [Abstract][Full Text] [Related]
5. Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy.
Kolwicz SC; Olson DP; Marney LC; Garcia-Menendez L; Synovec RE; Tian R
Circ Res; 2012 Aug; 111(6):728-38. PubMed ID: 22730442
[TBL] [Abstract][Full Text] [Related]
6. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
[TBL] [Abstract][Full Text] [Related]
7. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload.
Smeets PJ; Teunissen BE; Willemsen PH; van Nieuwenhoven FA; Brouns AE; Janssen BJ; Cleutjens JP; Staels B; van der Vusse GJ; van Bilsen M
Cardiovasc Res; 2008 Apr; 78(1):79-89. PubMed ID: 18187461
[TBL] [Abstract][Full Text] [Related]
8. Cardiomyocyte peroxisome proliferator-activated receptor α is essential for energy metabolism and extracellular matrix homeostasis during pressure overload-induced cardiac remodeling.
Wang X; Zhu XX; Jiao SY; Qi D; Yu BQ; Xie GM; Liu Y; Song YT; Xu Q; Xu QB; Gonzalez FJ; Du J; Wang XM; Qu AJ
Acta Pharmacol Sin; 2022 May; 43(5):1231-1242. PubMed ID: 34376812
[TBL] [Abstract][Full Text] [Related]
9. Differential mRNA Expression and Circular RNA-Based Competitive Endogenous RNA Networks in the Three Stages of Heart Failure in Transverse Aortic Constriction Mice.
Li X; Tan W; Zheng S; Pyle WG; Zhu C; Chen H; Kang L; Wu J; Zou Y; Backx PH; Yang FH
Front Physiol; 2022; 13():777284. PubMed ID: 35330931
[TBL] [Abstract][Full Text] [Related]
10. [Contribution of sympathetic activation to antihypertrophic memory after regression of exercise-induced physiological myocardial hypertrophy in mice].
Hu D; Huang X; Zheng C; Zhu Y; Chen L; Lin H; Liao Y
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):495-503. PubMed ID: 33963707
[TBL] [Abstract][Full Text] [Related]
11. Role of Exercise on Alleviating Pressure Overload-Induced Left Ventricular Dysfunction and Remodeling via AMPK-Dependent Autophagy Activation.
Ma Z; Qi J; Gao L; Zhang J
Int Heart J; 2020; 61(5):1022-1033. PubMed ID: 32999189
[TBL] [Abstract][Full Text] [Related]
12. Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression.
Byrne NJ; Levasseur J; Sung MM; Masson G; Boisvenue J; Young ME; Dyck JR
Cardiovasc Res; 2016 May; 110(2):249-57. PubMed ID: 26968698
[TBL] [Abstract][Full Text] [Related]
13. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice.
You J; Wu J; Jiang G; Guo J; Wang S; Li L; Ge J; Zou Y
J Cardiovasc Pharmacol; 2013 Feb; 61(2):142-51. PubMed ID: 23188126
[TBL] [Abstract][Full Text] [Related]
14. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.
You J; Wu J; Zhang Q; Ye Y; Wang S; Huang J; Liu H; Wang X; Zhang W; Bu L; Li J; Lin L; Ge J; Zou Y
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H552-H562. PubMed ID: 29196344
[TBL] [Abstract][Full Text] [Related]
15. AMPK regulates energy metabolism through the SIRT1 signaling pathway to improve myocardial hypertrophy.
Dong HW; Zhang LF; Bao SL
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2757-2766. PubMed ID: 29771428
[TBL] [Abstract][Full Text] [Related]
16. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway.
Meng RS; Pei ZH; Yin R; Zhang CX; Chen BL; Zhang Y; Liu D; Xu AL; Dong YG
Eur J Pharmacol; 2009 Oct; 620(1-3):63-70. PubMed ID: 19699196
[TBL] [Abstract][Full Text] [Related]
17. Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: evidence from fatty acid-binding protein-4 and -5 knockout mice.
Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Yamaguchi A; Hanaoka H; Hishiki T; Nagahata-Naito Y; Obinata H; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
Cardiovasc Res; 2018 Jul; 114(8):1132-1144. PubMed ID: 29554241
[TBL] [Abstract][Full Text] [Related]
18. Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
Kaimoto S; Hoshino A; Ariyoshi M; Okawa Y; Tateishi S; Ono K; Uchihashi M; Fukai K; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H305-H313. PubMed ID: 28011586
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
Peters T; Hermans-Beijnsberger S; Beqqali A; Bitsch N; Nakagawa S; Prasanth KV; de Windt LJ; van Oort RJ; Heymans S; Schroen B
PLoS One; 2016; 11(2):e0150236. PubMed ID: 26919721
[TBL] [Abstract][Full Text] [Related]
20. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
